Clinical Trial Update: INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing TRELEGY effectiveness in usual practice for COPD; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• TRELEGY

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2020-09-07